| Skin Squamous Cell Carcinoma altered in cohorts of …ALTERED_INderived171 of 171show fewer |
|---|
| ← altered in cohorts of | MUC12 24 / 25 cases (96 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PLEC 22 / 25 cases (88 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | WDFY4 22 / 25 cases (88 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HMCN2 21 / 25 cases (84 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD1 32 / 39 cases (82 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AKAP6 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CDH23 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC3A 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC5AC 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PPP1R3A 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRQ 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SHANK1 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TNRC18 20 / 25 cases (80 %) · ssm · cscc_ranson_2022 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ABCA13 31 / 39 cases (79 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCLO 31 / 39 cases (79 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT3 28 / 39 cases (72 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | XIRP2 28 / 39 cases (72 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TTN 58 / 83 cases (70 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC4 27 / 39 cases (69 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | VCAN 26 / 39 cases (67 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TP53 55 / 83 cases (66 %) · ssm · cscc_ucsf_2021 · largest of 4 cohorts | — | — | Skin Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC5B 25 / 39 cases (64 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR3 25 / 39 cases (64 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UNC13C 25 / 39 cases (64 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZFHX4 25 / 39 cases (64 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AHNAK2 24 / 39 cases (62 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CFH 24 / 39 cases (62 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL6A5 24 / 39 cases (62 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH11 24 / 39 cases (62 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH6 23 / 39 cases (59 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF469 23 / 39 cases (59 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CACNA1E 22 / 39 cases (56 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DGKB 22 / 39 cases (56 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH17 22 / 39 cases (56 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MROH2B 22 / 39 cases (56 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NEB 22 / 39 cases (56 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SCN9A 22 / 39 cases (56 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SLIT2 22 / 39 cases (56 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NOTCH1 46 / 83 cases (55 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL6A6 21 / 39 cases (54 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EYS 21 / 39 cases (54 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FPGT-TNNI3K 21 / 39 cases (54 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MGAM 21 / 39 cases (54 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYH2 21 / 39 cases (54 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYH8 21 / 39 cases (54 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TNXB 21 / 39 cases (54 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF831 21 / 39 cases (54 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CNTN5 20 / 39 cases (51 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ERBB4 20 / 39 cases (51 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GRIN2B 20 / 39 cases (51 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYO18B 20 / 39 cases (51 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PRDM9 20 / 39 cases (51 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SI 20 / 39 cases (51 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SVEP1 20 / 39 cases (51 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | THSD7A 20 / 39 cases (51 %) · ssm · cscc_hgsc_bcm_2014 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UNC80 20 / 39 cases (51 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | USH2A 40 / 83 cases (48 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD3 39 / 83 cases (47 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RELN 39 / 83 cases (47 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH5 38 / 83 cases (46 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP1B 37 / 83 cases (45 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPTA1 37 / 83 cases (45 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HMCN1 36 / 83 cases (43 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | APOB 35 / 83 cases (42 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT4 35 / 83 cases (42 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PKHD1 33 / 83 cases (40 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH8 32 / 83 cases (39 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC16 32 / 83 cases (39 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCDH15 32 / 83 cases (39 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE1 32 / 83 cases (39 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL11A1 31 / 83 cases (37 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL6A3 31 / 83 cases (37 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH7 30 / 83 cases (36 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP2 30 / 83 cases (36 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NOTCH2 30 / 83 cases (36 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR1 30 / 83 cases (36 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ANK2 29 / 83 cases (35 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL24A1 29 / 83 cases (35 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DCHS2 29 / 83 cases (35 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FLG 29 / 83 cases (35 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HYDIN 29 / 83 cases (35 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KALRN 29 / 83 cases (35 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BLTP1 28 / 83 cases (34 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FSIP2 28 / 83 cases (34 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LAMA2 28 / 83 cases (34 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGRB3 27 / 83 cases (33 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD2 27 / 83 cases (33 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2C 27 / 83 cases (33 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MDN1 27 / 83 cases (33 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC17 27 / 83 cases (33 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ALMS1 26 / 83 cases (31 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL22A1 26 / 83 cases (31 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH9 26 / 83 cases (31 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ERICH3 26 / 83 cases (31 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR2 26 / 83 cases (31 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | VWF 26 / 83 cases (31 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH10 25 / 83 cases (30 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT1 25 / 83 cases (30 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FBN1 25 / 83 cases (30 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FMN2 25 / 83 cases (30 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MACF1 25 / 83 cases (30 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ROS1 25 / 83 cases (30 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SALL1 25 / 83 cases (30 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AHNAK 24 / 83 cases (29 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CUBN 24 / 83 cases (29 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DYNC1H1 24 / 83 cases (29 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PAPPA2 24 / 83 cases (29 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PLCE1 24 / 83 cases (29 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ARID2 23 / 83 cases (28 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL1A2 23 / 83 cases (28 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH3 23 / 83 cases (28 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAM135B 23 / 83 cases (28 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYO15A 23 / 83 cases (28 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYO16 23 / 83 cases (28 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NF1 23 / 83 cases (28 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PEG3 23 / 83 cases (28 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SCN1A 23 / 83 cases (28 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UNC79 23 / 83 cases (28 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BSN 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CDKN2A 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CNTNAP2 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DMXL2 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH2 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DOCK2 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DSCAM 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT2 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HERC2 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LAMA1 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PLCB4 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RP1 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SLX4 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE2 22 / 83 cases (27 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ABCC9 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AKAP12 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | C6 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL12A1 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL19A1 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL4A1 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL4A4 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL5A2 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | F5 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FBN2 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FRY 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRRC7 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MDGA2 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYCBP2 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRT 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPAG17 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TRPM6 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | VPS13C 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF804B 21 / 83 cases (25 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGRV1 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ANK3 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ASH1L 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CMYA5 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CNTRL 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL4A3 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DMD 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2D 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | OBSCN 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PDZD2 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PIK3CG 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PKD1L1 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PKHD1L1 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PRUNE2 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SACS 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPEN 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPHKAP 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TG 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TMEM132D 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TRIO 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |